Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis - Contacts and Locations

Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

This study is currently recruiting participants.

Study NCT00598533. Last updated on March 13, 2008. Information provided by Deutsches Herzzentrum Muenchen

Please refer to this study by its ClinicalTrials.gov identifier: NCT00598533

Contacts


Contact: Adnan Kastrati, MD	+49 89 12 18-0 ext 4577	kastrati@dhm.mhn.de

Contact: Julinda Mehilli, MD	+49 89 12 18-0 ext 4582	mehilli@dhm.mhn.de

Locations


Germany
	Deutsches Herzzentrum Muenchen	Recruiting
	Munich, Germany, 80636
	Contact: Adnan Kastrati, MD +49 89 1218-0 ext 4577 kastrati@dhm.mhn.de
	Principal Investigator: Julinda Mehilli, MD
	Medizinische Klinik, Klinikum rechts der Isar	Recruiting
	Muenchen, Germany, 81675
	Contact: Josef Dirschinger, MD +49 89 4140 2947
	Principal Investigator: Josef Dirschinger, MD

Sponsors and Collaborators

Deutsches Herzzentrum Muenchen

Investigators


Study Chair:	Albert Schoemig, MD	Deutsches Herzzentrum Muenchen